Free Trial
→ Today's free pick (on me) (From Behind the Markets) (Ad)tc pixel
NASDAQ:LNSR

LENSAR Q3 2026 Earnings Date & Estimates

LENSAR logo
$5.45 -0.05 (-0.91%)
Closing price 11/6/2026 04:00 PM Eastern
Extended Trading
$5.44 -0.01 (-0.18%)
As of 11/6/2026 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LENSAR is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from LENSAR in Q3 2026

LENSAR is expected to post earnings of -$0.0950 per share on revenue of $14.30 million. In the same quarter a year earlier LENSAR reported -$0.31 per share on revenue of $14.32 million. LENSAR last reported on August 13, 2026, posting $0.10 per share and beating the -$0.1650 consensus estimate. LENSAR has beaten the consensus EPS estimate in 2 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.0950
Expected Revenue
$14.30 million
Prior-Year EPS
-$0.31
Prior-Year Revenue
$14.32 million
Expected Revenue Growth
-0.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.10 (Beat by +$0.2650)
Last Quarter Revenue
$16.50 million
EPS Beat Rate
2 of last 8 quarters

Prepare for the Q3 2026 Call

LENSAR Q3 2026 Earnings FAQ

LENSAR (NASDAQ:LNSR) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

LENSAR's Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect LENSAR to post earnings of -$0.0950 per share for Q3 2026.

The consensus revenue estimate for LENSAR is $14.30 million for Q3 2026.

LENSAR Earnings Headlines

LENSAR (NASDAQ:LNSR) & Orthofix Medical (NASDAQ:OFIX) Critical Comparison
November 5 at 4:05 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31180266
LENSAR (LNSR) Projected to Announce Quarterly Earnings on Tuesday
November 5 at 2:41 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31179185
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
 |  Behind the Markets (Ad)
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
November 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/03/3394140/0/en/lensar-to-report-third-quarter-2026-results-on-november-10th-2026.html
People to Know in Healthcare: Nick Curtis, Lensar
October 23, 2026  |  bizjournals.comhttps://www.bizjournals.com/orlando/news/2026/10/23/people-to-know-in-healthcare-nick-curtis.html
LENSAR, Inc. (LNSR) Latest Press Releases & Corporate News - Yahoo Finance
October 23, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/LNSR/press-releases/
See More LENSAR Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like LENSAR? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LENSAR and other key companies, straight to your email.

About LENSAR

LENSAR (NASDAQ:LNSR) is a medical technology company focused on ophthalmic laser systems used in cataract surgery and other procedures involving the eye. The company develops and commercializes femtosecond laser technology designed to assist surgeons with key steps of cataract surgery, including corneal incisions, capsulotomy and lens fragmentation.

Its product portfolio includes the LENSAR Laser System, which incorporates image-guidance and planning technologies intended to support precise, customized procedures. The company has also developed the LENSAR ALLY system, a next-generation platform designed to integrate multiple cataract-surgery functions into a single system. Related software and imaging capabilities are intended to help surgeons plan and perform procedures based on each patient’s ocular anatomy.

LENSAR markets its products to ophthalmic surgeons, ambulatory surgery centers and hospitals through direct and distribution channels. The company is based in Orlando, Florida, and serves customers in the United States and international markets. LENSAR became a publicly traded company on the Nasdaq under the symbol LNSR in 2021.

View LENSAR Profile
Earnings Tools